Is Your Med Spa ‘Ozempic’ What You Think It Is? We Investigated.

concerning its recent filing of trademark infringement and false advertising suits against “certain medical spas, weight loss or wellness clinics, and compounding pharmacies,” that it alleges are unlawfully using its trademarked brand names Ozempic or Wegovy when marketing and/or selling compounded products purporting to contain semaglutide that are not genuine Ozempic or Wegovy products. The suit also alleges that the FDA has not approved any generic versions of semaglutide.

For the patient, it’s not always clear from a company’s website—often the consumer’s first step in decision-making—whether prescribers are providing semaglutide compounded with something else. One surefire way to determine if you’re receiving Ozempic or Wegovy in its original form is to head to a specialist. Dr. Lonier, an endocrinologist, recommends getting a prescription for one of these drugs “from physicians who have the appropriate training in their use.

“Some weight loss clinics, pharmacies, and other companies claim to have availability of compounded ‘semaglutide’ products, including products that purport to offer ‘semaglutide’ in combination with other ingredients,” a Novo Nordisk spokesperson explains. “These compounded products do not have the same safety, quality, and effectiveness assurances as FDA-approved drugs, and may expose patients to potentially serious health risks.

There were shortages of Ozempic and Wegovy in late 2022 and early 2023, which were due to high demand, according to a. on May 25, before the FDA announced the latest Ozempic and Wegovy shortage at the end of May, Novo Nordisk said that all doses of Ozempic were available to pharmacies “for appropriate patients with type 2 diabetes,” and that pharmacies may experience “normal delays given the time required to order the product from their local distribution center, and geographical variabilities.

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Drugmaker behind Ozempic, Wegovy begins legal proceedings against certain med spas, clinics and compounding pharmacies | CNNPharmaceutical firm Novo Nordisk says it has begun legal proceedings against some US medical spas, weight loss or wellness clinics and compounding pharmacies “to cease and desist from false advertising, trademark infringement and/or unlawful sales of non-FDA approved compounded products claiming to contain semaglutide,” the active ingredient in its diabetes and weight-loss medications Ozempic, Wegovy and Rybelsus.
Source: cnni - 🏆 326. / 59 Read more »

Ozempic and Wegovy maker sues over compounded, off-brand versions of drugs used for weight lossIn a press release, the company said Tuesday that legal action is being taken against certain medical spas, weight loss or wellness clinics, and compounding pharmacies.
Source: ABC - 🏆 471. / 51 Read more »

Ozempic and Wegovy maker sues over off-brand versions of drugs used for weight lossIn a press release, the company said Tuesday that legal action is being taken against certain medical spas, weight loss or wellness clinics, and compounding pharmacies.
Source: 6abc - 🏆 250. / 63 Read more »

Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and WegovyDanish drugmaker Novo Nordisk initiated federal court lawsuits against medical spas and wellness clinics in New York, Texas, Florida and Tennessee.
Source: CNBC - 🏆 12. / 72 Read more »